Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 121.26
   
  • Change Today:
    $-2.81
  • 52 Week High: $128.07
  • 52 Week Low: $91.65
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 6,659,785
  • Market Cap: $151,090m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 121.26
Change Today $ -2.81
% Change -2.26 %
52 Week High $128.07
52 Week Low $91.65
Volume 6,659,785
Shares Issued 1,246.00m
Market Cap $151,090m
RiskGrade 120

Trades for 15-Jan-2026

Time Volume / Share Price
16:00 400 @ $121.35
16:00 900 @ $121.33
15:59 100 @ $121.27
15:59 200 @ $121.24
15:59 100 @ $121.24

Top of Page